Growth • IQVIA Hldgs
IQV
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
6,8%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
21,6%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
48,4%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
50,8%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
43,2%
CAGR Normalized EPS 5Y
Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.
13,9%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!